Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

ClinicalTrials.gov ID: NCT00067561

Public ClinicalTrials.gov record NCT00067561. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 8:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Twelve-Week, Randomized, Double Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of 0.5 mg QD, 1 mg QD and 1 mg BID of Alosetron in Female Subjects With Severe Diarrhea-predominant IBS Who Have Failed Conventional Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety and effectiveness of different doses of an investigational medication in women with severe diarrhea-predominant Irritable Bowel Syndrome (IBS) who have failed conventional therapy.

Study identification

NCT ID
NCT00067561
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
702 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2003 (Type not available)
Primary completion
Jan 2005 (Actual)
Completion
Jan 2005 (Actual)
Last update posted
Apr 16, 2015

2003 – 2005

United States locations

U.S. sites
177
U.S. states
38
U.S. cities
152
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35235 —
GSK Investigational Site Calera Alabama 35040 —
GSK Investigational Site Tuscaloosa Alabama 35406 —
GSK Investigational Site Phoenix Arizona 85006 —
GSK Investigational Site Tucson Arizona 85723 —
GSK Investigational Site Fayetteville Arkansas 72701 —
GSK Investigational Site Chula Vista California 91910 —
GSK Investigational Site Fountain Valley California 92708 —
GSK Investigational Site Garden Grove California 92840 —
GSK Investigational Site Lancaster California 93534 —
GSK Investigational Site Los Angeles California 90045 —
GSK Investigational Site Newport Beach California 92663 —
GSK Investigational Site Rancho Cucamonga California 91730 —
GSK Investigational Site Redlands California 92373 —
GSK Investigational Site San Diego California 92103 —
GSK Investigational Site San Diego California 92123 —
GSK Investigational Site San Rafael California 94901 —
GSK Investigational Site Santa Ana California 92704 —
GSK Investigational Site Santa Ana California 92705 —
GSK Investigational Site Upland California 91786 —
GSK Investigational Site Vista California 92084 —
GSK Investigational Site Yuba City California 95991 —
GSK Investigational Site Boulder Colorado 80304 —
GSK Investigational Site Colorado Springs Colorado 80907 —
GSK Investigational Site Colorado Springs Colorado 80909 —
GSK Investigational Site Englewood Colorado 80113 —
GSK Investigational Site Wheat Ridge Colorado 80033 —
GSK Investigational Site Manchester Connecticut 06040 —
GSK Investigational Site Boca Raton Florida 33486 —
GSK Investigational Site Boynton Beach Florida 33426 —
GSK Investigational Site Boynton Beach Florida 33437 —
GSK Investigational Site Coral Gables Florida 33134 —
GSK Investigational Site Fort Myers Florida 33907 —
GSK Investigational Site Fort Myers Florida 33916 —
GSK Investigational Site Hialeah Florida 33013 —
GSK Investigational Site Hollywood Florida 33021 —
GSK Investigational Site Lake Worth Florida 33461 —
GSK Investigational Site Longwood Florida 32779 —
GSK Investigational Site Miami Florida 33156 —
GSK Investigational Site Miami Florida 33186 —
GSK Investigational Site Naples Florida 34102 —
GSK Investigational Site New Port Richey Florida 34652 —
GSK Investigational Site Ocala Florida 34471 —
GSK Investigational Site Panama City Florida 32405 —
GSK Investigational Site Sarasota Florida 34232 —
GSK Investigational Site St. Petersburg Florida 33702 —
GSK Investigational Site Tallahassee Florida 32308 —
GSK Investigational Site Tampa Florida 33614 —
GSK Investigational Site West Palm Beach Florida 33407 —
GSK Investigational Site Zephyrhills Florida 33540 —
GSK Investigational Site Atlanta Georgia 30309 —
GSK Investigational Site Atlanta Georgia 30328 —
GSK Investigational Site Atlanta Georgia 30342 —
GSK Investigational Site Austell Georgia 30106 —
GSK Investigational Site Decatur Georgia 30033 —
GSK Investigational Site Marietta Georgia 30060 —
GSK Investigational Site Martinez Georgia 30907 —
GSK Investigational Site Savannah Georgia 31405 —
GSK Investigational Site Peoria Illinois 61602 —
GSK Investigational Site Riverside Illinois 60546 —
GSK Investigational Site Indianapolis Indiana 46250 —
GSK Investigational Site Indianapolis Indiana 46254 —
GSK Investigational Site South Bend Indiana 46601 —
GSK Investigational Site Overland Park Kansas 66211 —
GSK Investigational Site Bowling Green Kentucky 42101 —
GSK Investigational Site Louisville Kentucky 40202 —
GSK Investigational Site Louisville Kentucky 40291 —
GSK Investigational Site Madisonville Kentucky 42431 —
GSK Investigational Site Davenport Louisiana 52807 —
GSK Investigational Site Baltimore Maryland 21215 —
GSK Investigational Site Laurel Maryland 20707 —
GSK Investigational Site Silver Spring Maryland 20901 —
GSK Investigational Site Silver Spring Maryland 20910 —
GSK Investigational Site Towson Maryland 21204 —
GSK Investigational Site Attleboro Massachusetts 2703 —
GSK Investigational Site Boston Massachusetts 02114 —
GSK Investigational Site Boston Massachusetts 02215 —
GSK Investigational Site Ann Arbor Michigan 48109 —
GSK Investigational Site Detroit Michigan 48202 —
GSK Investigational Site Grand Rapids Michigan 49546 —
GSK Investigational Site Oak Park Michigan 48237 —
GSK Investigational Site Saint Joseph Michigan 49085 —
GSK Investigational Site Warren Michigan 48089 —
GSK Investigational Site Chaska Minnesota 55318 —
GSK Investigational Site Saint Paul Minnesota 55435 —
GSK Investigational Site Wentzville Minnesota 62285 —
GSK Investigational Site Jackson Mississippi 39202 —
GSK Investigational Site Jefferson City Missouri 65101 —
GSK Investigational Site Jefferson City Missouri 65109 —
GSK Investigational Site Kansas City Missouri 64131 —
GSK Investigational Site Missoula Montana 59802 —
GSK Investigational Site Lebanon New Hampshire 03756 —
GSK Investigational Site Bloomfield New Jersey 07003 —
GSK Investigational Site Egg Harbor New Jersey 08234 —
GSK Investigational Site Ocean City New Jersey 7712 —
GSK Investigational Site Vineland New Jersey 8360 —
GSK Investigational Site West Caldwell New Jersey 7006 —
GSK Investigational Site Farmington New Mexico 87401 —
GSK Investigational Site Bay Shore New York 11706 —
GSK Investigational Site Great Neck New York 11023 —
GSK Investigational Site Merrick New York 11566 —
GSK Investigational Site Rochester New York 14607 —
GSK Investigational Site Stony Brook New York 11794-8091 —
GSK Investigational Site Syracuse New York 13210 —
GSK Investigational Site Asheville North Carolina 28801 —
GSK Investigational Site Cary North Carolina 27511 —
GSK Investigational Site Chapel Hill North Carolina 27599 —
GSK Investigational Site Charlotte North Carolina 28207 —
GSK Investigational Site Fayetteville North Carolina 28304 —
GSK Investigational Site Greenville North Carolina 27858 —
GSK Investigational Site Hickory North Carolina 28601 —
GSK Investigational Site High Point North Carolina 27262 —
GSK Investigational Site Morehead City North Carolina 28557 —
GSK Investigational Site Raleigh North Carolina 27609 —
GSK Investigational Site Winston-Salem North Carolina 27103 —
GSK Investigational Site Bismarck North Dakota 58501 —
GSK Investigational Site Akron Ohio 44302 —
GSK Investigational Site Beavercreek Ohio 45431 —
GSK Investigational Site Cincinnati Ohio 45219 —
GSK Investigational Site Cincinnati Ohio 45220 —
GSK Investigational Site Cincinnati Ohio 45224 —
GSK Investigational Site Cleveland Ohio 44106 —
GSK Investigational Site Cleveland Ohio 44113 —
GSK Investigational Site Columbus Ohio 43212 —
GSK Investigational Site Dayton Ohio 45440 —
GSK Investigational Site Kettering Ohio 45429 —
GSK Investigational Site Lyndhurst Ohio 44124 —
GSK Investigational Site Oklahoma City Oklahoma 73104 —
GSK Investigational Site Oklahoma City Oklahoma 73112 —
GSK Investigational Site Tulsa Oklahoma 74136 —
GSK Investigational Site Medford Oregon 97504 —
GSK Investigational Site Altoona Pennsylvania 16602 —
GSK Investigational Site Fleetwood Pennsylvania 19522 —
GSK Investigational Site Hershey Pennsylvania 17033 —
GSK Investigational Site Lancaster Pennsylvania 19096 —
GSK Investigational Site Newtown Pennsylvania 18940 —
GSK Investigational Site Pittsburgh Pennsylvania 15212 —
GSK Investigational Site Wyomissing Pennsylvania 19610 —
GSK Investigational Site East Providence Rhode Island 02914 —
GSK Investigational Site Columbia South Carolina 29240 —
GSK Investigational Site Greenville South Carolina 29615 —
GSK Investigational Site Simpsonville South Carolina 29681 —
GSK Investigational Site Bristol Tennessee 37620 —
GSK Investigational Site Kingsport Tennessee 37660 —
GSK Investigational Site Memphis Tennessee 38119 —
GSK Investigational Site Memphis Tennessee 38120 —
GSK Investigational Site Murfreesboro Tennessee 37130 —
GSK Investigational Site Nashville Tennessee 37203 —
GSK Investigational Site Arlington Texas 76012 —
GSK Investigational Site Austin Texas 78745 —
GSK Investigational Site Corpus Christi Texas 78412 —
GSK Investigational Site Dallas Texas 75204 —
GSK Investigational Site Houston Texas 77024 —
GSK Investigational Site Houston Texas 77025 —
GSK Investigational Site Houston Texas 77030 —
GSK Investigational Site Humble Texas 77338 —
GSK Investigational Site Irving Texas 75061 —
GSK Investigational Site San Antonio Texas 78205 —
GSK Investigational Site San Antonio Texas 78229 —
GSK Investigational Site Sugar Land Texas 77478 —
GSK Investigational Site Tomball Texas 77375 —
GSK Investigational Site Bountiful Utah 84010 —
GSK Investigational Site Ogden Utah 84405 —
GSK Investigational Site West Jordan Utah 84088 —
GSK Investigational Site Alexandria Virginia 22304 —
GSK Investigational Site Charlottesville Virginia 22908 —
GSK Investigational Site Charlottesville Virginia 22911 —
GSK Investigational Site Chesapeake Virginia 23320 —
GSK Investigational Site Lacey Washington 98516 —
GSK Investigational Site Spokane Washington 99207 —
GSK Investigational Site Walla Walla Washington 99362 —
GSK Investigational Site Wenatchee Washington 98801 —
GSK Investigational Site Yakima Washington 98902 —
GSK Investigational Site Milwaukee Wisconsin 53209-0996 —
GSK Investigational Site Milwaukee Wisconsin 53212 —
GSK Investigational Site Milwaukee Wisconsin 53215 —
GSK Investigational Site Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00067561, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2015 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00067561 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →